CAR-T Cell Therapy Biomarkers: Kyoto U Discovery | AcademicJobs
Kyoto University researchers identify 4MD biomarkers predicting CAR-T therapy success in blood cancers, advancing precision oncology in Japan.
No reviews yet. Be the first to rate Itaru!
Itaru Kato serves as Senior Lecturer in the Graduate School of Medicine at Kyoto University, within the Faculty of Medicine. He earned his Ph.D. in Medicine from Kyoto University. His research centers on pediatric leukemia and tumor immunity, with additional focus in the areas of life sciences and tumor biology.
Kyoto University researchers identify 4MD biomarkers predicting CAR-T therapy success in blood cancers, advancing precision oncology in Japan.
Kyoto University team identifies CD38-CD73-Tim-3-HLA-DR+ biomarkers predicting CAR-T efficacy in BCP-ALL, advancing precision medicine at Japanese universities.
Photo by Mufid Majnun on Unsplash
Photo by Shubham Sharan on Unsplash
Photo by Shubham Sharan on Unsplash
Photo by Evan Marvell on Unsplash
Photo by Markus Winkler on Unsplash
Photo by Patrick Robert Doyle on Unsplash
Photo by Brandi Redd on Unsplash
Have a story or a research paper to share? Become an Expert Academic Contributor and publish your work on AcademicJobs.com.
Write news and research articles as a expert academic in your field publish your work on AcademicJobs.com
